Skip to content

Author

M.-K. Kim

We have 3 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

369. Integrating structured hospital-based psychosocial case management into national suicide prevention in South Korea: a multicentre, assessor-blinded, randomised controlled trial

Abstract Background South Korea maintains the highest suicide rate in the OECD despite ongoing prevention efforts. Major depressive disorder (MDD) is the leading diagnosis among suicide deaths, yet evidence for effective psychosocial interventions for suicidal ideation remains limited. Aims & Objectives This study eval...

S. Lee, K.-H. Kim, M. Baik et al. · 0 citations
Review Open access Sep 2026

247. Patterns of benzodiazepine polypharmacy in the treatment of panic disorder and generalized anxiety disorder

Abstract Background Panic disorder (PD) and generalized anxiety disorder (GAD) significantly impair daily functioning and cause substantial emotional distress, necessitating active and timely treatment. Although selective serotonin reuptake inhibitors and serotonin–norepinephrine reuptake inhibitors are first-line phar...

E. Moon, J. Seo, M.-K. Kim et al. · 0 citations
Open access Sep 2026

394. Association of COVID-19 vaccination with improved treatment adherence in patients with schizophrenia: a nationwide propensity score-matched cohort study

It is indicated that COVID-19 vaccination is safe in patients with schizophrenia and is not associated with an increased risk of psychiatric decompensation or treatment escalation, and vaccination was linked to improved treatment adherence, suggesting potential benefits beyond infection prevention.

S. Jung, Y. An, W. Shin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.